Literature DB >> 165484

Plasminogen-independent fibrinolysis by proteases produced by transformed chick embryo fibroblasts.

L B Chen, J M Buchanan.   

Abstract

The fibrinolytic activity of proteases secreted by chick embryo fibroblasts infected with Rous sarcoma virus was studied by use of a procedure in which a fibrin clot was formed with highly purified fibrinogen and thrombin above the cell layer. This procedure results in the formation of fibrin that is apparently a more suitable substrate for studies on fibrinolysis than is fibrin prepared by other methods. Since neither plasminogen nor serum were included in the assay system in the present studies, the fibrinolytic activity observed cannot be ascribed to the conversion of the plasminogen in serum to plasmin by a plasminogen activator produced by transformed cells. Our procedure, therefore, measures proteolytic activities other than those reported by previous investigators. Maintenance of some of the transformed phenotypes of Rous sarcoma virus transformed chick embryo fibroblasts such as morpholigical change and increased rate of glucose uptake apparently does not depend on the presence of plasminogen in the culture medium.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165484      PMCID: PMC432480          DOI: 10.1073/pnas.72.3.1132

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Purification of human plasminogen and plasmin by gel filtration on Sephadex and chromatography on diethylaminoethyl-Sephadex.

Authors:  D C ROBBINS; L SUMMARIA
Journal:  J Biol Chem       Date:  1963-03       Impact factor: 5.157

2.  The polymerization of proteins; the action of thrombin on fibrinogen.

Authors:  K LAKI
Journal:  Arch Biochem Biophys       Date:  1951-07       Impact factor: 4.013

3.  Fibrinolysis associated with oncogenic transformation. Morphological correlates.

Authors:  L Ossowski; J P Quigley; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

4.  Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

Authors:  J K Christman; G Acs
Journal:  Biochim Biophys Acta       Date:  1974-03-27

5.  Temperature-dependent alterations in sugar transport in cells infected by a temperature-sensitive mutant of Rous sarcoma virus.

Authors:  G S Martin; S Venuta; M Weber; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

6.  The secretion of fibrinolysin by cultured rat ovarian tumor cells.

Authors:  A A Yunis; D R Schultz; G H Sato
Journal:  Biochem Biophys Res Commun       Date:  1973-06-08       Impact factor: 3.575

7.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

8.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

9.  Mitogenic activity of blood components. I. Thrombin and prothrombin.

Authors:  L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration.

Authors:  L Ossowski; J P Quigley; G M Kellerman; E Reich
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  12 in total

1.  Surface ruffles as markers for studies of cell transformation by Rous sarcoma virus.

Authors:  V R Ambros; L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

2.  Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus.

Authors:  D Becker; R Kurth; D Critchley; R Friis; H Bauer
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

3.  Phenotypes of Rous sarcoma virus-transformed fibroblasts: an argument for a multifunctional Src gene product.

Authors:  R R Friis; R T Schwarz; M F Schmidt
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

4.  Human skin proteases. Fractionation of psoriasis scale proteases and separation of a plasminogen activator and a histone hydrolysing protease.

Authors:  J E Fräki; V K Hopsu-Havu
Journal:  Arch Dermatol Res       Date:  1976-08-27       Impact factor: 3.017

Review 5.  Fibronectin: a review of its structure and biological activity.

Authors:  E Pearlstein; L I Gold; A Garcia-Pardo
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

6.  A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells.

Authors:  A Aoyama; W T Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Transformation-dependent secretion of a low molecular weight protein by murine fibroblasts.

Authors:  M M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

8.  Binding and internalization of thrombin by normal and transformed chick cells.

Authors:  B R Zetter; L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

9.  Diverse mitogenic agents induce the phosphorylation of two related 42,000-dalton proteins on tyrosine in quiescent chick cells.

Authors:  J A Cooper; B M Sefton; T Hunter
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

10.  Rous-sarcoma-virus-transformed fibroblasts having low levels of plasminogen activator.

Authors:  B A Wolf; A R Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.